Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

EU Project Studies Innovative Ways Of Diagnosing and Treating Cancer

10.03.2005


A project to study new and innovative ways of diagnosing and treating cancer is underway thanks to a grant of 10.4 million euros from the ’Life sciences, genomics and biotechnology for health’ thematic area of the EU’s Sixth Framework Programme (FP6).



CANCERDEGRADOME brings together the expertise of 41 scientists from 13 countries who, looking mainly on four of the most prolific types of cancer (breast, prostate, colorectal and skin), will focus on the complement of genes that encode enzymes that are known as proteases.

“Proteases are a diverse and important group of enzymes whose job is to cut or degrade other proteins”, says project co-ordinator Dylan Edwards, from the University of East Anglia. “Proteases function at different stages of tumour development and progression. In this project we plan to investigate the biology of proteases and then design specific inhibitors to block them.”


“One of the major problems we face in treating cancer is that patients who have the same type of cancer and are at the same disease stage respond very differently to therapy. So ideally we should look to identify those who are most at risk from their disease and provide them with treatment while, at the same time, sparing those who are not at risk from undergoing costly, unpleasant and unnecessary interventions.”

During the four-year project the CANCERDEGRADOME partners will use their knowledge of the degradome to create new drugs and develop novel specific interventions based on detailed knowledge of the roles of target proteases in cancer. The project will also aim to improve tumour imaging, so that cancers can be localised, characterised and treated at the earliest possible stages of the disease.

“The fight against cancer is a priority issue for the EU”, says Claire Horton, FP6UK’s National Contact Point for ’Life sciences, genomics and biotechnology for health. “Especially as it is estimated that our increasingly ageing population will lead to an extra 250,000 cancer diagnoses every year in Europe by 2020. That is why the European Cancer Proteases Consortium aims to improve the diagnosis of cancer so that patients can be identified when the disease is in its earliest, most treatable stage.

“The current Framework Programme (FP6) runs until 2006 and organisations wanting free information on how to access some of the 19 billion euros available should log on to http://fp6uk.ost.gov.uk or call central telephone support on 0870 600 6080.”

Dave Sanders | alfa
Further information:
http://fp6uk.ost.gov.uk

More articles from Health and Medicine:

nachricht Minimising risks of transplants
22.02.2018 | Friedrich-Alexander-Universität Erlangen-Nürnberg

nachricht FAU researchers demonstrate that an oxygen sensor in the body reduces inflammation
22.02.2018 | Friedrich-Alexander-Universität Erlangen-Nürnberg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Developing reliable quantum computers

International research team makes important step on the path to solving certification problems

Quantum computers may one day solve algorithmic problems which even the biggest supercomputers today can’t manage. But how do you test a quantum computer to...

Im Focus: In best circles: First integrated circuit from self-assembled polymer

For the first time, a team of researchers at the Max-Planck Institute (MPI) for Polymer Research in Mainz, Germany, has succeeded in making an integrated circuit (IC) from just a monolayer of a semiconducting polymer via a bottom-up, self-assembly approach.

In the self-assembly process, the semiconducting polymer arranges itself into an ordered monolayer in a transistor. The transistors are binary switches used...

Im Focus: Demonstration of a single molecule piezoelectric effect

Breakthrough provides a new concept of the design of molecular motors, sensors and electricity generators at nanoscale

Researchers from the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), Institute of Physics of the CAS (IP CAS) and Palacký University...

Im Focus: Hybrid optics bring color imaging using ultrathin metalenses into focus

For photographers and scientists, lenses are lifesavers. They reflect and refract light, making possible the imaging systems that drive discovery through the microscope and preserve history through cameras.

But today's glass-based lenses are bulky and resist miniaturization. Next-generation technologies, such as ultrathin cameras or tiny microscopes, require...

Im Focus: Stem cell divisions in the adult brain seen for the first time

Scientists from the University of Zurich have succeeded for the first time in tracking individual stem cells and their neuronal progeny over months within the intact adult brain. This study sheds light on how new neurons are produced throughout life.

The generation of new nerve cells was once thought to taper off at the end of embryonic development. However, recent research has shown that the adult brain...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

2nd International Conference on High Temperature Shape Memory Alloys (HTSMAs)

15.02.2018 | Event News

Aachen DC Grid Summit 2018

13.02.2018 | Event News

How Global Climate Policy Can Learn from the Energy Transition

12.02.2018 | Event News

 
Latest News

Stiffness matters

22.02.2018 | Life Sciences

Magnetic field traces gas and dust swirling around supermassive black hole

22.02.2018 | Physics and Astronomy

First evidence of surprising ocean warming around Galápagos corals

22.02.2018 | Earth Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>